Ruth de Tute

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Multiple Myeloma

Placebo Controlled

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Jaimal Kothari, Toby Andrew Eyre, Ali Rismani, Kushani Ediriwickrema, Darren Edwards, Sevasti Galani, William Wilson, Anthony Lawrie, Laura Clifton-Hadley, Helen McCarthy, Angela Collins, David Lewis, Suzanne Arulogan, Rebecca Auer, Guy Pratt, Ruth de Tute, Roger Owen, Shirley D'Sa
PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia. British journal of haematology (2024)
Wei Yee Chan, Nicholas Counsell, Ruth de Tute, Dunnya De-Silva, Elizabeth H Phillips, Jamie Cavenagh, Toyin Adedayo, Nivette Braganca, Claire Roddie, Matthew Streetly, Stephen Schey, Mickey B C Koh, Josephine Crowe, Treen C Morris, Curly T C M Morris, Laura Clifton-Hadley, Neil Rabin, Roger G Owen, Rakesh Popat, Kwee L Yong, null null
Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial. British journal of haematology (2021)
Rakesh Popat, Nicholas Counsell, Ruth de Tute, Dunnya De-Silva, Elizabeth H Phillips, Jamie D Cavenagh, Toyin Adedayo, Nivette Braganca, Claire Roddie, Matthew Streetly, Steve Schey, Mickey B C Koh, Josephine Crowe, Treen C Morris, Curly T C M Morris, Paul Smith, Laura Clifton-Hadley, Neil Rabin, Roger Owen, Kwee L Yong, null null
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial. British journal of haematology 193 (3) (2021)